Abstract
Recently, we showed that post cyclophosphamide (CTX) microenvironment benefits the function of transferred T cells. Analysis of the kinetics of cellular recovery after CTX treatment showed that a single 4mg/mouse CTX treatment decreased the absolute number of leukocytes in the peripheral blood (PBL) at days 3-15, and in the spleen and bone marrow (BM) at days 3-6. The absolute numbers of CD11c +CD11b - and CD11c +CD11b + dendritic cells (DCs), CD11b + and Ly6G + myeloid cells, T and B cells, CD4 +CD25 + T regulatory (T reg) cells, and NK1.1 + cells also decreased. The cell numbers returned to control levels during the recovery phase. The absolute numbers of B cells remained low for 3weeks. The numbers of DCs increased in PBL and spleen at day 9 but returned to control levels at day 15. These data indicate that CTX alters the cellular microenvironment in kinetics that might be precisely targeted to benefit the host. © 2012 Elsevier Inc.
Author supplied keywords
Cite
CITATION STYLE
Salem, M. L., Al-Khami, A. A., El-Nagaar, S. A., Zidan, A. A. A., Al-Sharkawi, I. M., Marcela Díaz-Montero, C., & Cole, D. J. (2012). Kinetics of rebounding of lymphoid and myeloid cells in mouse peripheral blood, spleen and bone marrow after treatment with cyclophosphamide. Cellular Immunology, 276(1–2), 67–74. https://doi.org/10.1016/j.cellimm.2012.03.010
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.